|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Dynamic model- ing of a dual clearance squeeze film damper:Part I test rigand dynamic model with one damper显示文摘 | Moraru L Keith T G Jr Dimofte F | 2003 | Tribology Trans- actions2003，46，2： | 1 |
| 2 | Effects of simulated acidic rain on yields of field-grown crops显示文摘 | LNACE S E KEITH F L ELIZABETH A C | 1982 | New Phytol1982，91，： | 1 |
| 3 | Dynamic model- ing of a dual clearance squeeze film damper: Part II 显示文摘 | Moraru L Keith T G Jr Dimofte F | 2006 | Tribology Transactions2006，49，4： | 1 |
| 4 | Effects of simulated acidic rain on yields of field- grown crops 显示文摘 | Lance S E Keith F L Elizabeth A C | 1982 | New Phytologist1982，91，： | 1 |
| 5 | Characterization of polyploid wheat genomic diversity using a high-density 90 000 single nucleotide polymorphism array 显示文摘 | Wang SC Debbie W Kerrie F Alexandra A Shiaoman C Bevan EH Marco M Silvio S Sara GM Luigi C Anna MM Alex W Stuart S Gary B Ralf W Joerg P International Wheat Genome Sequencing Consortium Morten L Diane M Rudi A Rudy D Gina BG Abraham K Alina RA Catherine F Jerome S Michele M Curtis P Luo MC Jan DMM Jorge D Martin G Roberto T Cindy L Ivan M Colin C Keith JE Matthew H Eduard A | 2014 | Plant Biotechnol J2014，12，： | 1 |
| 6 | How Changing the Focus of Attention Affects Performance, Kinematics, and Electromyography in Dart Throwing 显示文摘 | Keith R L David E S Alice F H | 2010 | Human Movement Science2010，29，： | 1 |
| 7 | Journal o{ Inorganic Biochemistry 显示文摘 | Wolfhardt F Loria M Alessandra C Chiara B Keith F T Wolf gang L Laura El C | 2008 | 102 13292008，102，： | 1 |
| 8 | The measurement of residual stresses in thermal barrier coated model aerofoils显示文摘 | DONG L PETER F KEITH R H | | 0，，： | 1 |
| 9 | Experimental study of tetrodotoxin,a Long-activing topoical anesthetic显示文摘 | Daniel M S Howard L F Keith G D | 1998 | Am J of Ophthalmol1998，125，4： | 1 |
| 10 | Dynamic modeling of a dual clearance squeeze film damper:Part Ⅰ test rig and dynamic model with one damper显示文摘 | Moraru L Keith T G Jr Dimofte F | 2003 | Tribology Transactions2003，46，2： | 1 |
| 11 | Dynamic modeling of a dual clearance squeeze film damper:Part Ⅱ 显示文摘 | Moraru L Keith T G Dimofte F | 2006 | Tribology Transactions2006，49，4： | 1 |
| 12 | Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results显示文摘AIM To assess the real-world effectiveness and cost of simeprevir(SMV), and/or sofosbuvir(SOF)-based therapy for chronic hepatitis C virus(HCV) infection.METHODS The real-world performance of patients treated with SMV/SOF ± ribavirin(RBV), SOF/RBV, and SOF/RBV with pegylated-interferon(PEG) were analyzed in a consecutive series of 508 patients with chronic HCV infection treated at a single academic medical center. Patients with genotypes 1 through 4 were included. Rates of sustained virological response-the absence of a detectable serum HCV RNA 12 wk after the end of treatment [sustained virological response(SVR) 12]-were calculated on an intention-to-treat basis. Costs were calculated from the payer's perspective using Medicare/Medicaid fees and Redbook Wholesale Acquisition Costs. Patient-related factors associated with SVR12 were identified using multivariable logistic regression.RESULTS SVR 12 rates were as follows: 86%(95%CI: 80%-91%)among 178 patients on SMV/SOF ± RBV; 62%(95%CI: 55%-68%) among 234 patients on SOF/RBV; and 78%(95%CI: 68%-86%) among 96 patients on SOF/PEG/RBV. Mean costs-per-SVR 12 were $174442(standard deviation: ± $18588) for SMV/SOF ± RBV; $223003(± $77946) for SOF/RBV; and $126496(± $31052) for SOF/PEG/RBV. Among patients on SMV/SOF ± RBV, SVR12 was less likely in patients previously treated with a protease inhibitor [odds ratio(OR): 0.20, 95%CI: 0.06-0.56]. Higher bilirubin(OR: 0.47, 95%CI: 0.30-0.69) reduced the likelihood of SVR12 among patients on SOF/RBV, while FIB-4 score ≥ 3.25 reduced the likelihood of SVR 12(OR: 0.18, 95%CI: 0.05-0.59) among those on SOF/PEG/RBV. CONCLUSION SVR 12 rates for SMV and/or SOF-based regimens in a diverse real-world population are comparable to those in clinical trials. Treatment failure accounts for 27% of costs. | Kian Bichoupan Neeta Tandon James F Crismale Joshua Hartman David Del Bello Neal Patel Sweta Chekuri Alyson Harty Michel Ng Keith M Sigel Meena B Bansal Priya Grewal Charissa Y Chang Jennifer Leong Gene Y Im Lawrence U Liu Joseph A Odin Nancy Bach Scott L Friedman Thomas D Schiano Ponni V Perumalswami Douglas T Dieterich Andrea D Branch | 2017 | World Journal of Virology2017，6，4： | 1 |
| 13 | Dynamic modeling of a dual clearance squeeze film damper: part ITest rig and dynamic model with one damper显示文摘 | MORARU L KEITH T G DIMOFTE F | 2003 | Tribology Transactions2003，46，2： | 1 |
| 14 | Soil nutrient audits for China to estimate nutrient balances and output/input relationships显示文摘 | William F S Keith S John L | 2003 | Agriculture Ecosystems and Environment2003，94，： | 1 |
| 15 | Differ ent regulatory mechanisms modulate the expression of a dinoflagellate iron-superoxide dismutase显示文摘 | O Keith Okamoto Deborah L Robertson Thomas F Fagan | 2001 | The Journal of Biological Chemistry2001，23，19： | 1 |
| 16 | The distally based sural flap for foot and ankle reconstruction 显示文摘 | Howard L Keith E F Alessio B | 2007 | Techniques in Foot and Ankle Surgery2007，6，2： | 1 |
| 17 | Linkage heterogeneity between X-linked retinitis pigmentosa and a map of 10 RFLP loci 显示文摘 | Chen JD Halliday F Keith G Sheffield L Dickinson P Gray R | 1989 | Am J Hum Genet1989，45，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员